‌

US Patent 10822313 Selective sulfonation of benzodiazepine derivatives

Patent 10822313 was granted and assigned to ImmunoGen on November, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

ImmunoGen

Current Assignee

ImmunoGen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

108223130

Date of Patent

November 3, 2020

Patent Application Number

166691210

Date Filed

October 30, 2019

Patent Citations

‌

US Patent 10287256 Selective sulfonation of benzodiazepine derivatives

‌

US Patent 10077313 Anti-CD123 antibodies and conjugates and derivatives thereof

‌

US Patent 10494348 Selective sulfonation of benzodiazepine derivatives

Patent Citations Received

‌

US Patent 11572349 Selective sulfonation of benzodiazepine derivatives

Patent Primary Examiner

‌

Erich A Leeser

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10822313 Selective sulfonation of benzodiazepine derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API